Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof.
[EN] METHODS FOR THE IDENTIFICATION OF PHOSPHATIDYLINOSITOL KINASE INTERACTING MOLECULES AND FOR THE PURIFICATION OF PHOSPHATIDYLINOSITOL KINASE PROTEINS<br/>[FR] PROCÉDÉS PERMETTANT L'IDENTIFICATION DE MOLÉCULES INTERAGISSANT AVEC LES PHOSPHATIDYLINOSITOL KINASES, ET LA PURIFICATION DE PROTÉINES PHOSPHATIDYLINOSITOL KINASES
申请人:CELLZOME AG
公开号:WO2010133318A1
公开(公告)日:2010-11-25
The present invention relates to immobilization compounds of formula (I), immobilization products and preparations thereof as well as methods and uses for the identification of phosphatidylinositol kinase interacting compounds or for the purification or identification of phosphatidylinositol kinase proteins.
A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).